2006
Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism
Anderson GM, Scahill L, McCracken JT, McDougle CJ, Aman MG, Tierney E, Arnold LE, Martin A, Katsovich L, Posey DJ, Shah B, Vitiello B. Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism. Biological Psychiatry 2006, 61: 545-550. PMID: 16730335, DOI: 10.1016/j.biopsych.2006.02.032.Peer-Reviewed Original ResearchConceptsRisperidone-induced increasesLong-term risperidone treatmentProlactin levelsRisperidone treatmentSerum prolactinOpen-label followWeeks of risperidoneBaseline prolactin levelsEffects of ShortPlacebo groupProlactin elevationReceptor polymorphismsWeek 8Baseline levelsMean increaseProlactinRisperidoneSerum samplesAdverse effectsPlaceboChildrenTreatmentMonthsDRD2 allelesAdolescentsParent Management Training: Treatment for Oppositional, Aggressive, and Antisocial Behavior in Children and Adolescents Parent Management Training: Treatment for Oppositional, Aggressive, and Antisocial Behavior in Children and Adolescents .By Alan E. Kazdin. New York: Oxford University Press, 424 pp., $54.50 (hardcover).
Sukhodolsky D, Martin A. Parent Management Training: Treatment for Oppositional, Aggressive, and Antisocial Behavior in Children and Adolescents Parent Management Training: Treatment for Oppositional, Aggressive, and Antisocial Behavior in Children and Adolescents .By Alan E. Kazdin. New York: Oxford University Press, 424 pp., $54.50 (hardcover). Journal Of The American Academy Of Child & Adolescent Psychiatry 2006, 45: 256-257. DOI: 10.1097/01.chi.0000190472.31566.ae.Commentaries, Editorials and Letters
2003
Low-Dose Fluvoxamine Treatment of Children and Adolescents with Pervasive Developmental Disorders: A Prospective, Open-Label Study
Martin A, Koenig K, Anderson GM, Scahill L. Low-Dose Fluvoxamine Treatment of Children and Adolescents with Pervasive Developmental Disorders: A Prospective, Open-Label Study. Journal Of Autism And Developmental Disorders 2003, 33: 77-85. PMID: 12708582, DOI: 10.1023/a:1022234605695.Peer-Reviewed Original ResearchConceptsPervasive developmental disorderSelective serotonin reuptake inhibitor responseOpen-label studyOpen-label trialLow-dose fluvoxamineDevelopmental disordersPremature discontinuationClinical responseFluvoxamine treatmentPartial respondersMean ageSerotonin levelsSelect childrenPubertal statusInhibitor responseBehavioral activationFluvoxamineChildrenFurther investigationDisordersTreatmentGender differencesAdolescentsSubjectsTolerability